Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ron Dagan

25PUBLICATIONS
35CO-AUTHORS
Infant and child healthPacific Peoples early childhood educationInnate immunityNanotoxicology, health and safetyNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

Sort by Publication Date:
|Apr 08, 2026
Is the interplay between maternal Tdap and pneumococcal conjugate vaccines relevant to infant pneumococcal carriage?

Corinne Levy, Ron Dagan, Stéphane Béchet

|Dec 05, 2025
Differential Impact of Pneumococcal Conjugate Vaccines on Hospitalized <i>Versus</i> Outpatient Community-Acquired Alveolar Pneumonia in Children Younger Than 5 Years Suggests Differences in Pathogenesis.

Bart A van der Beek, David Greenberg, Guy Hazan

|Mar 07, 2025
Decline in Community-Acquired Alveolar Pneumonia Positive for Respiratory Syncytial Virus in Hospitalized Children Following Implementation of Pneumococcal Conjugate Vaccine (PCV) in Israel.

Ron Dagan, Bart Adriaan van der Beek, Tal Grupel

|Mar 04, 2025
Estimating the Serotype-Specific Association Between the Concentration of Vaccine-Induced Serum Antibodies and Protection Against Pneumococcal Colonization.

Anabelle Wong, Joshua L Warren, Laura Fitch

|Dec 17, 2024
Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine Is Reduced in Infants Immunized During the Respiratory Viral Season.

Ron Dagan, Bart A van der Beek

|Dec 10, 2024
Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo: Analysis From a Phase 3 Randomized Clinical Trial (MELODY).

Doug Arbetter, Vancheswaran Gopalakrishnan, Anastasia A Aksyuk

Pageof 5

Frequent Collaborators

4 joint publications

Shabir A Madhi

3 joint publications

Elizabeth J Kelly

2 joint publications

Anastasia A Aksyuk

2 joint publications

Ann Marie Stanley

2 joint publications

William J Muller

2 joint publications

Shalom Ben-Shimol

2 joint publications

Benjamin Sparklin

2 joint publications

Johnathan D Guest

2 joint publications

Khitam Muhsen

2 joint publications

Luwy Musey

Frequent Collaborators

4 joint publications

Shabir A Madhi

3 joint publications

Elizabeth J Kelly

2 joint publications

Anastasia A Aksyuk

2 joint publications

Ann Marie Stanley

Top Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on : Feb 23, 2014

15.8K
See more related videos

Top Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on : Feb 23, 2014

15.8K
See more related videos